Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""AMYLOIDOSIS"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-25 z 32050

Starter badań:

Tytuł:
Needs of amyloidosis patients and their care providers: design & first results of the  A MY-NEED S research and care program.
Autorzy:
Ihne-Schubert SM; Interdisciplinary Amyloidosis Center of Northern Bavaria, University Hospital of Würzburg, Würzburg, Germany. ihne_.; Department of Internal Medicine II, Hematology, University Hospital of Würzburg, Würzburg, Germany. ihne_.; Department of Internal Medicine IV, University Hospital of Gießen and Marburg, Gießen, Germany. ihne_.; Centre for Innovation Research, Lund University, Lund, Sweden. ihne_.
Radovic T; Technical University of Applied Sciences Würzburg-Schweinfurt, Würzburg, Germany.
Fries S; Interdisciplinary Amyloidosis Center of Northern Bavaria, University Hospital of Würzburg, Würzburg, Germany.; Technical University of Applied Sciences Würzburg-Schweinfurt, Würzburg, Germany.
Frantz S; Interdisciplinary Amyloidosis Center of Northern Bavaria, University Hospital of Würzburg, Würzburg, Germany.; Comprehensive Heart Failure Center (CHFC), University and University Hospital of Würzburg, Würzburg, Germany.; Department of Internal Medicine I, Cardiology, University Hospital of Würzburg, Würzburg, Germany.
Einsele H; Interdisciplinary Amyloidosis Center of Northern Bavaria, University Hospital of Würzburg, Würzburg, Germany.; Department of Internal Medicine II, Hematology, University Hospital of Würzburg, Würzburg, Germany.
Störk S; Interdisciplinary Amyloidosis Center of Northern Bavaria, University Hospital of Würzburg, Würzburg, Germany.; Comprehensive Heart Failure Center (CHFC), University and University Hospital of Würzburg, Würzburg, Germany.; Department of Internal Medicine I, Cardiology, University Hospital of Würzburg, Würzburg, Germany.
Neuderth S; Technical University of Applied Sciences Würzburg-Schweinfurt, Würzburg, Germany.
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Feb 10; Vol. 19 (1), pp. 58. Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:
Journal Article
MeSH Terms:
Caregivers*/psychology
Amyloidosis*
Humans ; Health Personnel ; Focus Groups
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Preclinical evaluation of Tc-99m p5+14 peptide for SPECT detection of cardiac amyloidosis.
Autorzy:
Kennel SJ; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States of America.
Jackson JW; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States of America.
Stuckey A; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States of America.
Richey T; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States of America.
Foster JS; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States of America.
Wall JS; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 05; Vol. 19 (4), pp. e0301756. Date of Electronic Publication: 2024 Apr 05 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Amyloidosis*/diagnostic imaging
Amyloidosis*/metabolism
Cardiomyopathies*/diagnostic imaging
Humans ; Mice ; Animals ; Positron Emission Tomography Computed Tomography ; Tomography, Emission-Computed, Single-Photon/methods ; Peptides ; Amyloid/metabolism ; Prealbumin
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Catheter ablation of atrial arrhythmias in cardiac amyloidosis: Impact on heart failure and mortality.
Autorzy:
Maury P; Department of Cardiology, University Hospital Toulouse, Toulouse, France.; I2MC, INSERM UMR 1297, Toulouse, France.
Sanchis K; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Djouadi K; Department of Cardiology, University Hospital Henri Mondor, Creteil, France.
Cariou E; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Delasnerie H; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Boveda S; Clinique Pasteur, Toulouse, France.
Fournier P; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Itier R; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Mondoly P; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Voglimacci-Stephanopoli Q; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Beneyto M; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Dhanjal TS; Department of Cardiology, University of Warwick, Coventry, United Kingdom.
Rollin A; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Damy T; Department of Cardiology, University Hospital Henri Mondor, Creteil, France.
Lairez O; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Lellouche N; Department of Cardiology, University Hospital Henri Mondor, Creteil, France.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 05; Vol. 19 (4), pp. e0301753. Date of Electronic Publication: 2024 Apr 05 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Atrial Fibrillation*/complications
Atrial Fibrillation*/surgery
Tachycardia, Supraventricular*
Heart Failure*/complications
Heart Failure*/surgery
Amyloidosis*/complications
Amyloidosis*/surgery
Catheter Ablation*/adverse effects
Humans ; Retrospective Studies ; Treatment Outcome ; Neoplasm Recurrence, Local/surgery
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lymphocytic Myocarditis with Increased Left Ventricular Thickness: A Rare Presentation Mimicking Cardiac Amyloidosis.
Autorzy:
Duan X; Department of Cardiovascular Medicine, The Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Jinhua, Zhejiang, China (mainland).
Qu L; Department of Cardiovascular Medicine, The Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Jinhua, Zhejiang, China (mainland).
Chen H; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Zhejiang University School, Hangzhou, Zhejiang, China (mainland).
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2024 Mar 25; Vol. 25, pp. e942760. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Myocarditis*/diagnosis
Amyloidosis*/diagnosis
Atrial Fibrillation*
Male ; Humans ; Aged, 80 and over ; Myocardium/pathology ; Echocardiography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer's disease.
Autorzy:
Van Hoecke L; VIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, Ghent, 9052, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, 9000, Belgium.
Vandenbroucke RE; VIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, Ghent, 9052, Belgium. .; Department of Biomedical Molecular Biology, Ghent University, Ghent, 9000, Belgium. .
Pokaż więcej
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2024 Mar 18; Vol. 12 (1), pp. 41. Date of Electronic Publication: 2024 Mar 18.
Typ publikacji:
Letter
MeSH Terms:
Alzheimer Disease*/genetics
Amyloidosis*/genetics
Mice ; Animals ; Amyloid beta-Peptides/genetics ; Disease Models, Animal
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Proximity-Induced Pharmacology for Amyloid-Related Diseases.
Autorzy:
Bertran-Mostazo A; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.; Institute of Biomedicine (IBUB), University of Barcelona, 08028 Barcelona, Spain.
Putriūtė G; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.
Álvarez-Berbel I; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.
Busquets MA; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.; Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain.
Galdeano C; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.; Institute of Biomedicine (IBUB), University of Barcelona, 08028 Barcelona, Spain.
Espargaró A; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.; Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain.
Sabate R; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.; Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Mar 04; Vol. 13 (5). Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Alzheimer Disease*/metabolism
Amyloidosis*
Humans ; Amyloid beta-Peptides/metabolism ; Plaque, Amyloid/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.
Autorzy:
Bosch ME; Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, USA.
Dodiya HB; Department of Neurobiology, University of Chicago, Chicago, USA.
Michalkiewicz J; Department of Neurobiology, University of Chicago, Chicago, USA.
Lee C; Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, USA.
Shaik SM; Department of Neurobiology, University of Chicago, Chicago, USA.
Weigle IQ; Department of Neurobiology, University of Chicago, Chicago, USA.
Zhang C; Genetics and Aging Research Unit, McCance Center for Brain Health, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Osborn J; Department of Neurobiology, University of Chicago, Chicago, USA.
Nambiar A; Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, USA.
Patel P; Center for Genetic Medicine, Northwestern University, Chicago, USA.
Parhizkar S; Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, USA.
Zhang X; Department of Neurobiology, University of Chicago, Chicago, USA.
Laury ML; Genome Technology Access Center, Washington University in St. Louis, St. Louis, USA.
Mondal P; Genetics and Aging Research Unit, McCance Center for Brain Health, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Gomm A; Genetics and Aging Research Unit, McCance Center for Brain Health, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Schipma MJ; Center for Genetic Medicine, Northwestern University, Chicago, USA.
Mallah D; Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Butovsky O; Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Chang EB; Department Medicine, Section of Gastroenterology, Hepatology, and Nutrition, The University of Chicago, Chicago, USA.
Tanzi RE; Genetics and Aging Research Unit, McCance Center for Brain Health, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Gilbert JA; Department of Pediatrics and Scripps Institution of Oceanography, UCSD, San Diego, USA.
Holtzman DM; Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, USA. .
Sisodia SS; Department of Neurobiology, University of Chicago, Chicago, USA. .
Pokaż więcej
Źródło:
Molecular neurodegeneration [Mol Neurodegener] 2024 Feb 17; Vol. 19 (1), pp. 18. Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/metabolism
Gastrointestinal Microbiome*
Amyloidosis*/metabolism
Humans ; Mice ; Male ; Female ; Animals ; Microglia/metabolism ; Mice, Transgenic ; Amyloid beta-Peptides/metabolism ; Plaque, Amyloid/pathology ; Amyloid/metabolism ; Amyloidogenic Proteins/metabolism ; Disease Models, Animal
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Assessment of potential transthyretin amyloid cardiomyopathy cases in the Brazilian public health system using a machine learning model.
Autorzy:
Zuppo Laper I; IQVIA Brazil, São Paulo, São Paulo, Brazil.
Camacho-Hubner C; Pfizer Global, New York City, New York, United States of America.
Vansan Ferreira R; IQVIA Brazil, São Paulo, São Paulo, Brazil.
Leite Bertoli de Souza C; Pfizer Brazil, São Paulo, São Paulo, Brazil.
Simões MV; Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
Fernandes F; Heart Institute, University of São Paulo, São Paulo, Brazil.
de Barros Correia E; Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.
de Jesus Lopes de Abreu A; IQVIA Brazil, São Paulo, São Paulo, Brazil.
Silva Julian G; Pfizer Brazil, São Paulo, São Paulo, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 15; Vol. 19 (2), pp. e0278738. Date of Electronic Publication: 2024 Feb 15 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Amyloidosis*
Cardiomyopathies*/diagnosis
Cardiomyopathies*/epidemiology
Amyloid Neuropathies, Familial*/diagnosis
Amyloid Neuropathies, Familial*/epidemiology
Humans ; Brazil/epidemiology ; Prealbumin ; Public Health ; Retrospective Studies ; Machine Learning
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Perinatal choline supplementation prevents learning and memory deficits and reduces brain amyloid Aβ42 deposition in AppNL-G-F Alzheimer's disease model mice.
Autorzy:
Bellio TA; Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.
Laguna-Torres JY; Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.
Campion MS; Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.
Chou J; Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.
Yee S; Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.
Blusztajn JK; Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.
Mellott TJ; Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 05; Vol. 19 (2), pp. e0297289. Date of Electronic Publication: 2024 Feb 05 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/drug therapy
Alzheimer Disease*/prevention & control
Alzheimer Disease*/pathology
Amyloidosis*/pathology
Pregnancy ; Female ; Mice ; Animals ; Mice, Transgenic ; Lactation ; Disease Models, Animal ; Brain/metabolism ; Choline/pharmacology ; Memory Disorders/drug therapy ; Memory Disorders/prevention & control ; Memory Disorders/pathology ; Maze Learning ; Dietary Supplements ; Amyloid beta-Peptides/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Successful Treatment of Systemic Light Chain Amyloidosis with Liver Involvement using Low-Frequency Daratumumab: A Case Report.
Autorzy:
Meng X; Department of Hematology, Bone Marrow Transplantation Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China (mainland).
He J; Department of Hematology, Bone Marrow Transplantation Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China (mainland).
Cheng F; Department of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China (mainland).
Yan H; Department of Cardiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China (mainland).
Zhu C; Department of Hematology, Bone Marrow Transplantation Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China (mainland).
Guo X; Department of Hematology, Bone Marrow Transplantation Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China (mainland).
Li Y; Department of Hematology, Bone Marrow Transplantation Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China (mainland).
Cai Z; Department of Hematology, Bone Marrow Transplantation Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China (mainland).
He D; Department of Hematology, Bone Marrow Transplantation Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China (mainland).
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2024 Jan 17; Vol. 25, pp. e942534. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Immunoglobulin Light-chain Amyloidosis*/drug therapy
Immunoglobulin Light-chain Amyloidosis*/diagnosis
Amyloidosis*/diagnosis
Amyloidosis*/drug therapy
Male ; Humans ; Middle Aged ; Antibodies, Monoclonal/therapeutic use ; Dexamethasone/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Tubular basement membrane amyloid deposition: is it an indicator of renal progression in light chain amyloidosis?
Autorzy:
Markóth C; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Kálmán Laki Doctoral School, University of Debrecen, Debrecen, Hungary.
Bidiga L; Kálmán Laki Doctoral School, University of Debrecen, Debrecen, Hungary.; Institute of Pathology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Váróczy L; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
File I; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Balla J; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Kálmán Laki Doctoral School, University of Debrecen, Debrecen, Hungary.
Mátyus J; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Kálmán Laki Doctoral School, University of Debrecen, Debrecen, Hungary.
Pokaż więcej
Źródło:
Renal failure [Ren Fail] 2023 Dec; Vol. 45 (1), pp. 2203776.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Amyloidosis*/diagnosis
Amyloidosis*/pathology
Kidney Diseases*/diagnosis
Kidney Diseases*/pathology
Humans ; Kidney/pathology ; Kidney Glomerulus/pathology ; Basement Membrane/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Assessing the prognostic utility of hematologic response for overall survival in patients with newly diagnosed AL amyloidosis: results of a meta-analysis.
Autorzy:
Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Misra A; Cytel, Rotterdam, Netherlands.
Gurskyte L; Cytel, Rotterdam, Netherlands.
Kroi F; Cytel, Rotterdam, Netherlands.
Verhoek A; Cytel, Rotterdam, Netherlands.
Vermeulen J; Janssen Research & Development, LLC, Leiden, Netherlands.
Ammann E; Janssen Global Services, LLC, Raritan, NJ, USA.
Lam A; Janssen Global Services, LLC, Raritan, NJ, USA.
Cote S; Janssen Global Services, LLC, Raritan, NJ, USA.
Wechalekar AD; National Amyloidosis Centre, University College London, London, UK.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2157581.
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article
MeSH Terms:
Immunoglobulin Light-chain Amyloidosis*/diagnosis
Immunoglobulin Light-chain Amyloidosis*/therapy
Humans ; Prognosis ; Remission Induction ; Proportional Hazards Models
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
[Giant tongue leading to dysphagia in light chain amyloidosis patient].
Autorzy:
Gómez-Piña JJ; Instituto Mexicano del Seguro Social, Centro Médico Nacional La Raza, Hospital de Especialidades 'Antonio Fraga Mouret', Servicio de Medicina Interna. Ciudad de México, México.
Quiroz DM; Instituto Mexicano del Seguro Social, Centro Médico Nacional La Raza, Hospital de Especialidades 'Antonio Fraga Mouret', Servicio de Patología Clínica. Ciudad de México, México.
Sierra-Hernández A; Instituto Mexicano del Seguro Social, Centro Médico Nacional La Raza, Hospital de Especialidades 'Antonio Fraga Mouret', Servicio de Medicina Interna. Ciudad de México, México.
Mendoza-Álvarez SA; Instituto Mexicano del Seguro Social, Centro Médico Nacional La Raza, Hospital de Especialidades 'Antonio Fraga Mouret', Servicio de Medicina Interna. Ciudad de México, México.
Vera-Lastra OL; Instituto Mexicano del Seguro Social, Centro Médico Nacional La Raza, Hospital de Especialidades 'Antonio Fraga Mouret', Servicio de Medicina Interna. Ciudad de México, México.
Pokaż więcej
Transliterated Title:
Lengua gigante condicionante de disfagia en paciente con amiloidosis de cadenas ligeras.
Źródło:
Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2023 Nov 06; Vol. 61 (6), pp. 863-867. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:
Case Reports; English Abstract; Journal Article
MeSH Terms:
Macroglossia*/etiology
Deglutition Disorders*/diagnosis
Deglutition Disorders*/etiology
Amyloidosis*/complications
Amyloidosis*/diagnosis
Male ; Humans ; Middle Aged ; Congo Red
SCR Disease Name:
Congenital macroglossia
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Histological evaluation of the distribution of systemic AA-amyloidosis in nine domestic shorthair cats.
Autorzy:
Moccia V; Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, PD, Italy.
Vogt AC; Department for BioMedical Research, Faculty of Medicine, University of Bern, Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Ricagno S; Department of Biosciences, University of Milano, Milano, MI, Italy.
Callegari C; IDEXX Laboratories, Milano, MI, Italy.
Vogel M; Department for BioMedical Research, Faculty of Medicine, University of Bern, Bern, Switzerland.
Zini E; Department of Animal Medicine, Production and Health, University of Padova, Legnaro, PD, Italy.; AniCura Istituto Veterinario Novara, Granozzo con Monticello, NO, Italy.; Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Ferro S; Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, PD, Italy.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Nov 02; Vol. 18 (11), pp. e0293892. Date of Electronic Publication: 2023 Nov 02 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Amyloidosis*/pathology
Immunoglobulin Light-chain Amyloidosis*/complications
Humans ; Cats ; Animals ; Plaque, Amyloid/complications ; Congo Red ; Amyloid ; Serum Amyloid A Protein ; Amyloidogenic Proteins
SCR Disease Name:
AA amyloidosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Re-Engineering Therapeutic Anti-Aβ Monoclonal Antibody to Target Amyloid Light Chain.
Autorzy:
Bai J; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
Li X; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
Zhao J; Cancer and Inflammation Program, National Cancer Institute, Frederick, MD 21702, USA.
Zong H; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.; Jecho Biopharmaceutical Institute, Shanghai 200240, China.
Yuan Y; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
Wang L; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
Zhang X; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
Ke Y; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
Han L; Jecho Biopharmaceutical Institute, Shanghai 200240, China.
Xu J; School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China.
Ma B; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
Zhang B; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
Zhu J; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.; Jecho Biopharmaceutical Institute, Shanghai 200240, China.; Jecho Laboratories, Inc., Frederick, MD 21704, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 27; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 27.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/metabolism
Alzheimer Disease*/therapy
Amyloidosis*/therapy
Antibodies, Monoclonal, Humanized*/pharmacology
Antibodies, Monoclonal, Humanized*/therapeutic use
Humans ; Amyloid/metabolism ; Amyloid beta-Peptides/immunology ; Amyloid beta-Peptides/metabolism ; Amyloidogenic Proteins/therapeutic use ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use ; Peptide Fragments/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Isolated Valve Amyloid Deposition in Aortic Stenosis: Potential Clinical and Pathophysiological Relevance.
Autorzy:
Conte M; Department of Translational Medical Sciences, University of Naples Federico II, Via S. Pansini, 5, 80131 Naples, Italy.; Casa di Cura San Michele, 81024 Caserta, Italy.
Poggio P; Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.
Monti M; Dipartimento di Scienze Chimiche, University of Naples Federico II, 5, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate, Via Gaetano Salvatore 486, 80145 Naples, Italy.
Petraglia L; Department of Translational Medical Sciences, University of Naples Federico II, Via S. Pansini, 5, 80131 Naples, Italy.
Cabaro S; Department of Translational Medical Sciences, University of Naples Federico II, Via S. Pansini, 5, 80131 Naples, Italy.
Bruzzese D; Department of Public Health, University of Naples Federico II, 5, 80131 Naples, Italy.
Comentale G; Department of Advanced Biomedical Science, University of Naples Federico II, 5, 80131 Naples, Italy.
Caruso A; Casa di Cura San Michele, 81024 Caserta, Italy.
Grimaldi M; Casa di Cura San Michele, 81024 Caserta, Italy.
Zampella E; Department of Advanced Biomedical Science, University of Naples Federico II, 5, 80131 Naples, Italy.
Gencarelli A; Department of Advanced Biomedical Science, University of Naples Federico II, 5, 80131 Naples, Italy.
Cervasio MR; Department of Advanced Biomedical Science, University of Naples Federico II, 5, 80131 Naples, Italy.
Cozzolino F; Dipartimento di Scienze Chimiche, University of Naples Federico II, 5, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate, Via Gaetano Salvatore 486, 80145 Naples, Italy.
Monaco V; Dipartimento di Scienze Chimiche, University of Naples Federico II, 5, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate, Via Gaetano Salvatore 486, 80145 Naples, Italy.
Myasoedova V; Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.
Valerio V; Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.
Ferro A; Institute of Biostructure and Bioimaging, CNR, 80145 Naples, Italy.
Insabato L; Department of Advanced Biomedical Science, University of Naples Federico II, 5, 80131 Naples, Italy.
Bellino M; Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, 84081 Salerno, Italy.
Galasso G; Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, 84081 Salerno, Italy.
Graziani F; Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Pucci P; Dipartimento di Scienze Chimiche, University of Naples Federico II, 5, 80131 Naples, Italy.
Formisano P; Department of Translational Medical Sciences, University of Naples Federico II, Via S. Pansini, 5, 80131 Naples, Italy.
Pilato E; Department of Advanced Biomedical Science, University of Naples Federico II, 5, 80131 Naples, Italy.
Cuocolo A; Department of Advanced Biomedical Science, University of Naples Federico II, 5, 80131 Naples, Italy.
Perrone Filardi P; Department of Advanced Biomedical Science, University of Naples Federico II, 5, 80131 Naples, Italy.
Leosco D; Department of Translational Medical Sciences, University of Naples Federico II, Via S. Pansini, 5, 80131 Naples, Italy.
Parisi V; Department of Translational Medical Sciences, University of Naples Federico II, Via S. Pansini, 5, 80131 Naples, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 18; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Aortic Valve Stenosis*
Amyloidosis*
Calcinosis*
Humans ; Catheters ; Calcification, Physiologic ; Interleukin-1beta
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Extending the reach of expert amyloidosis care: A feasibility study exploring the staged implementation of a UK amyloidosis network.
Autorzy:
Choy CH; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Steeds RP; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Pinney J; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Baig S; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Turvey-Haigh L; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Wahid Y; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Cox H; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Zaphiriou A; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Srinivasan V; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Wilson D; Department of Cardiology, Worcestershire Royal Hospital, Worcester, UK.
Fryearson J; Department of Cardiology, Warwick Hospital, South Warwickshire University NHS Foundation Trust, Warwick, UK.
Ahamed M; Department of Cardiology, Birmingham Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Lim S; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Chue C; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Pratt G; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Fontana M; Centre for Amyloidosis, Division of Medicine (Royal Free Campus), University College London, London, UK.
Gillmore JD; Centre for Amyloidosis, Division of Medicine (Royal Free Campus), University College London, London, UK.
Moody WE; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. Electronic address: .
Pokaż więcej
Źródło:
Clinical medicine (London, England) [Clin Med (Lond)] 2024 Jan; Vol. 24 (1), pp. 100004. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Journal Article
MeSH Terms:
Prealbumin*
Amyloidosis*
Humans ; Male ; Aged ; Feasibility Studies ; Ambulatory Care Facilities ; London
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Cardiac Amyloidosis: Clinical Features, Pathogenesis, Diagnosis, and Treatment.
Autorzy:
Argon A; Department of Pathology, Health Sciences University, Izmir Faculty of Medicine, IZMIR, TURKEY.
Nart D; Ege University, Faculty of Medicine, IZMIR, TURKEY.
Yilmazbarbet F; Ege University, Faculty of Medicine, IZMIR, TURKEY.
Pokaż więcej
Transliterated Title:
Cardiac Amyloidosis: Clinical Features, Pathogenesis, Diagnosis, and Treatment.
Źródło:
Turk patoloji dergisi [Turk Patoloji Derg] 2024; Vol. 40 (1), pp. 1-9.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiomyopathies*/etiology
Cardiomyopathies*/genetics
Amyloidosis*/diagnosis
Amyloidosis*/therapy
Humans ; Prognosis ; Immunoglobulin Light Chains
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Clinical, Endoscopic, and Histopathologic Observations in Gastrointestinal Amyloidosis.
Autorzy:
Krauß LU; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious diseases, University Hospital Regensburg, Regensburg, Germany. . .
Schmid S; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious diseases, University Hospital Regensburg, Regensburg, Germany. . .
Mester P; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious diseases, University Hospital Regensburg, Regensburg, Germany. .
Utpatel K; Institute of Pathology, University of Regensburg, Regensburg, Germany. .
Kunst C; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious diseases, University Hospital Regensburg, Regensburg, Germany. .
Müller M; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious diseases, University Hospital Regensburg, Regensburg, Germany. .
Pavel V; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious diseases, University Hospital Regensburg, Regensburg, Germany. .
Pokaż więcej
Źródło:
Journal of gastrointestinal and liver diseases : JGLD [J Gastrointestin Liver Dis] 2023 Dec 22; Vol. 32 (4), pp. 497-506. Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:
Journal Article
MeSH Terms:
Gastrointestinal Diseases*/diagnosis
Gastrointestinal Diseases*/etiology
Amyloidosis*/diagnosis
Amyloidosis*/pathology
Humans ; Male ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Female ; Retrospective Studies ; Gastrointestinal Hemorrhage/etiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
27-hydroxycholesterol causes cognitive deficits by disturbing Th17/Treg balance and the related immune responses in mild cognitive impairment patients and C57BL/6J mice.
Autorzy:
Wang T; School of Public Health, Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, No.10 Xitoutiao, You An Men Wai, Beijing, China.
Feng W; School of Public Health, Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, No.10 Xitoutiao, You An Men Wai, Beijing, China.
Ju M; School of Public Health, Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, No.10 Xitoutiao, You An Men Wai, Beijing, China.
Yu H; School of Public Health, Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, No.10 Xitoutiao, You An Men Wai, Beijing, China.
Guo Z; School of Public Health, Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, No.10 Xitoutiao, You An Men Wai, Beijing, China.
Sun X; School of Public Health, Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, No.10 Xitoutiao, You An Men Wai, Beijing, China.
Yang K; School of Public Health, Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, No.10 Xitoutiao, You An Men Wai, Beijing, China.
Liu M; School of Public Health, Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, No.10 Xitoutiao, You An Men Wai, Beijing, China.
Xiao R; School of Public Health, Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, No.10 Xitoutiao, You An Men Wai, Beijing, China. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2023 Dec 19; Vol. 20 (1), pp. 305. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Journal Article
MeSH Terms:
Cognitive Dysfunction*/metabolism
Amyloidosis*/pathology
Humans ; Mice ; Animals ; Transforming Growth Factor beta1/metabolism ; Interleukin-17/metabolism ; T-Lymphocytes, Regulatory ; Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism ; Th17 Cells ; Mice, Inbred C57BL ; Case-Control Studies ; Leukocytes, Mononuclear/metabolism ; Cytokines/metabolism ; Cognition ; Forkhead Transcription Factors/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Autologous Stem Cell Transplant in Hodgkin's and Non-Hodgkin's Lymphoma, Multiple Myeloma, and AL Amyloidosis.
Autorzy:
Alnasser SM; Department of Pharmacology and Toxicology, Unaizah College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia.
Alharbi KS; Department of Pharmacology and Toxicology, Unaizah College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia.
Almutairy AF; Department of Pharmacology and Toxicology, Unaizah College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia.
Almutairi SM; Unaizah College of Pharmacy, Qassim University, Buraydah 52571, Saudi Arabia.
Alolayan AM; Unaizah College of Pharmacy, Qassim University, Buraydah 52571, Saudi Arabia.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Dec 18; Vol. 12 (24). Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*/therapy
Immunoglobulin Light-chain Amyloidosis*/therapy
Lymphoma, Non-Hodgkin*/therapy
Humans ; Transplantation, Autologous ; Stem Cell Transplantation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Amyloid detection and typing yield of skin biopsy in systemic amyloidosis and polyneuropathy.
Autorzy:
Pinton S; Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Neurodegenerative disorders lab, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Vacchi E; Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Neurodegenerative disorders lab, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
Chiaro G; Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Neurodegenerative disorders lab, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Raimondi A; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.; Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Tzankov A; Histopathology, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Gerber B; Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; University of Zurich, Zurich, Switzerland.
Gobbi C; Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
Kaelin-Lang A; Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Neurodegenerative disorders lab, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Melli G; Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Neurodegenerative disorders lab, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2023 Dec; Vol. 10 (12), pp. 2347-2359. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Small Fiber Neuropathy*
Amyloidosis*/diagnosis
Amyloidosis*/metabolism
Polyneuropathies*
Peripheral Nervous System Diseases*
Humans ; Case-Control Studies ; Amyloid/metabolism ; Biopsy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Renal tubular and glomerular estrogen receptor ß levels are lower in lupus nephritis than in familial Mediterranean fever-associated renal amyloidosis.
Autorzy:
Kor A; Department of Rheumatology, Aksaray Education and Research Hospital, Aksaray, Turkey.
Süngü N; Department of Medical Pathology, Faculty of Medicine Ankara City Hospital, Ankara Yıldırım Beyazıt University, Ankara, Turkey.
Biçer C; Department of Medical Biochemistry, Faculty of Medicine Ankara City Hospital, Ankara Yıldırım Beyazıt University, Ankara, Turkey.
Erten Ş; Department of Rheumatology, Faculty of Medicine Ankara City Hospital, Ankara Yıldırım Beyazıt University, Ankara, Turkey.
Pokaż więcej
Źródło:
Lupus [Lupus] 2023 Nov; Vol. 32 (13), pp. 1536-1547. Date of Electronic Publication: 2023 Oct 31.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Nephritis*/pathology
Familial Mediterranean Fever*/complications
Lupus Erythematosus, Systemic*
Kidney Diseases*
Amyloidosis*/etiology
Humans ; Female ; Receptors, Estrogen ; Retrospective Studies ; Antibodies, Antineutrophil Cytoplasmic ; Creatinine ; Estrogens
SCR Disease Name:
Amyloidosis, familial visceral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Diagnostics of preeclampsia based on Congo red binding to urinary components: Rationales and limitations.
Autorzy:
Fedotov SA; Laboratory of Amyloid Biology, Saint Petersburg University, St. Petersburg, Russia.; Laboratory of Toxinology and Molecular Systematics, L.A. Orbeli Institute of Physiology, National Academy of Sciences of the Republic of Armenia, Yerevan, Armenia.; Laboratory of Comparative Behavioral Genetics, Pavlov Institute of Physiology, Russian Academy of Sciences, St. Petersburg, Russia.
Khrabrova MS; Laboratory of Amyloid Biology, Saint Petersburg University, St. Petersburg, Russia.; Department of Propaedeutics of Internal disease, Pavlov University, St. Petersburg, Russia.
Vashukova ES; Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, St. Petersburg, Russia.
Glotov AS; Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, St. Petersburg, Russia.
Anpilova AO; Laboratory of Amyloid Biology, Saint Petersburg University, St. Petersburg, Russia.; Research Institute of Nephrology, Pavlov University, St. Petersburg, Russia.
Dobronravov VA; Research Institute of Nephrology, Pavlov University, St. Petersburg, Russia.
Velizhanina ME; Laboratory of Amyloid Biology, Saint Petersburg University, St. Petersburg, Russia.
Rubel AA; Laboratory of Amyloid Biology, Saint Petersburg University, St. Petersburg, Russia.; Department of Genetics and Biotechnology, St. Petersburg State University, St. Petersburg, Russia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 19; Vol. 19 (1), pp. e0297144. Date of Electronic Publication: 2024 Jan 19 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Pre-Eclampsia*/metabolism
Hypertension*
Amyloidosis*/pathology
Humans ; Female ; Pregnancy ; Congo Red ; Amyloid/metabolism ; Amyloidogenic Proteins ; Proteinuria/diagnosis ; Proteinuria/urine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development and validation of a diagnostic nomogram model for predicting monoclonal gammopathy of renal significance.
Autorzy:
Dong Y; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; School of Medicine, Zhengzhou University, Zhengzhou, Henan, China.
Yan G; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; School of Medicine, Zhengzhou University, Zhengzhou, Henan, China.
Zhang Y; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; School of Medicine, Zhengzhou University, Zhengzhou, Henan, China.
Zhou Y; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; School of Medicine, Zhengzhou University, Zhengzhou, Henan, China.
Zhu L; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; School of Medicine, Zhengzhou University, Zhengzhou, Henan, China.
Shang J; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. .; Laboratory Animal Platform of Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 10; Vol. 14 (1), pp. 990. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Precancerous Conditions*
Monoclonal Gammopathy of Undetermined Significance*
Amyloidosis*
Humans ; Nomograms ; Kidney
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-25 z 32050

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies